Arabic Arabic English English French French German German
dark

Experts call for better design of early drug trials for Alzheimer’s and related dementias

An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology, the medical journal of the American Academy of Neurology. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Sinomenine exerts antidepressant effects in mice by promoting the hippocampal BDNF signaling pathway.

Next Post

Novel simulation method predicts blood flow conditions behind von Willebrand disease

Related Posts
Total
0
Share